Christopher Butler to Hospitalization
This is a "connection" page, showing publications Christopher Butler has written about Hospitalization.
Connection Strength
0.094
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
Score: 0.025
-
Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study. Pharmacoepidemiol Drug Saf. 2019 06; 28(6):857-866.
Score: 0.022
-
Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data. PLoS Med. 2018 09; 15(9):e1002652.
Score: 0.021
-
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol. BMJ Open. 2018 07 12; 8(7):e021032.
Score: 0.020
-
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
Score: 0.006